Our findings indicate that AMGB has the potential to control TNF-alpha, mTOR, extracellular signal-regulated kinases (ERK), IRS, and PI3K, consequently improving the insulin signaling pathway and preventing type II diabetes mellitus ( Supplementary Figure S1). This evidence concerns the gene MTOR and type 2 diabetes mellitus.